TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

PROZAC

FLUOXETINE HYDROCHLORIDE
Neurology Approved 1987-12-29
12
Indications
--
Phase 3 Trials
3
Priority Reviews
38
Years on Market

Details

Status
Prescription
First Approved
1987-12-29
Routes
ORAL
Dosage Forms
CAPSULE, TABLET, SOLUTION

Companies

Active Ingredient: FLUOXETINE HYDROCHLORIDE

PROZAC Approval History

Loading approval history...

What PROZAC Treats

6 indications

PROZAC is approved for 6 conditions since its original approval in 1987. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Major Depressive Disorder
  • Obsessive Compulsive Disorder
  • Bulimia Nervosa
  • Panic Disorder
  • Bipolar I Disorder
  • Treatment Resistant Depression
Source: FDA Label

PROZAC Boxed Warning

SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older [see Warnings and Precautions ( 5.1 )] . In patients of all ages who are started on antidepressant therapy, monitor...

Drugs Similar to PROZAC

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
FLUOXETINE HYDROCHLORIDE
5 shared
Teva
Shared indications:
Major Depressive DisorderObsessive Compulsive DisorderBulimia Nervosa +2 more
PAROXETINE
PAROXETINE HYDROCHLORIDE
3 shared
PRINSTON INC
Shared indications:
Major Depressive DisorderObsessive Compulsive DisorderPanic Disorder
EFFEXOR XR
VENLAFAXINE HYDROCHLORIDE
2 shared
UPJOHN
Shared indications:
Major Depressive DisorderPanic Disorder
PAXIL CR
PAROXETINE HYDROCHLORIDE
2 shared
Apotex
Shared indications:
Major Depressive DisorderPanic Disorder
VENLAFAXINE HYDROCHLORIDE
VENLAFAXINE HYDROCHLORIDE
2 shared
MEDICAP LABS
Shared indications:
Major Depressive DisorderPanic Disorder
ABILIFY ASIMTUFII
ARIPIPRAZOLE
1 shared
OTSUKA
Shared indications:
Bipolar I Disorder
APLENZIN
BUPROPION HYDROBROMIDE
1 shared
BAUSCH
Shared indications:
Major Depressive Disorder
ASENAPINE MALEATE
ASENAPINE MALEATE
1 shared
BRECKENRIDGE
Shared indications:
Bipolar I Disorder
AUVELITY
BUPROPION HYDROCHLORIDE
1 shared
AXSOME
Shared indications:
Major Depressive Disorder
CAPLYTA
LUMATEPERONE TOSYLATE
1 shared
INTRA-CELLULAR
Shared indications:
Major Depressive Disorder
CELEXA
CITALOPRAM HYDROBROMIDE
1 shared
AbbVie
Shared indications:
Major Depressive Disorder
CLONAZEPAM
CLONAZEPAM
1 shared
Novartis
Shared indications:
Panic Disorder
CONTRAVE
BUPROPION HYDROCHLORIDE
1 shared
NALPROPION
Shared indications:
Major Depressive Disorder
DESVENLAFAXINE SUCCINATE
DESVENLAFAXINE SUCCINATE
1 shared
ALEMBIC
Shared indications:
Major Depressive Disorder
DRIZALMA SPRINKLE
DULOXETINE HYDROCHLORIDE
1 shared
Sun Pharma
Shared indications:
Major Depressive Disorder
EMSAM
SELEGILINE
1 shared
SOMERSET
Shared indications:
Major Depressive Disorder
EXXUA
GEPIRONE HYDROCHLORIDE
1 shared
FABRE KRAMER
Shared indications:
Major Depressive Disorder
FANAPT
ILOPERIDONE
1 shared
VANDA PHARMS INC
Shared indications:
Bipolar I Disorder
FETZIMA
LEVOMILNACIPRAN HYDROCHLORIDE
1 shared
AbbVie
Shared indications:
Major Depressive Disorder
FLUVOXAMINE MALEATE
FLUVOXAMINE MALEATE
1 shared
Teva
Shared indications:
Obsessive Compulsive Disorder
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PROZAC FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

PROZAC ® is indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder [see Clinical Studies ] . Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD) [see Clinical Studies ]. Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa [see Clinical Studies ] . Acute treatment of Panic Disorder, with or without agoraphobia [see Clinical Studies ]. PROZAC and Olanzapine in Combination is indicated for the treatment of: Acute treatment of d...

⚠️ BOXED WARNING

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies. These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients ove...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.